Development of this product was supported with funding from the Centers for Disease Control and Prevention under cooperative
agreement CDC-RFA-PS21-2105 "National Viral Hepatitis Education, Awareness, and Capacity Building for Communities and Providers,"
award #NU51PS005194.
Despite advances in effective therapies, viral hepatitis rates continue to increase, especially among certain communities,
identified as priority health populations. These populations include people who inject drugs (PWID), Asians/Pacific Islanders
(APIs), American Indians/Alaska Natives (AIANs), and non-Hispanic Black persons. Furthermore, systemic barriers, stigma, and
discrimination impede access to health services for people at increased risk for viral hepatitis. These factors contribute
to missed/late diagnosis, onward transmission, costly tertiary care, and reduced quality of life. This collection of CME-certified
activities provides strategies to overcome barriers and deliver equitable care to further the achievement of hepatitis elimination
goals in the United States and worldwide.
Medscape Education© Medscape, LLC
Are you following the latest viral hepatitis vaccination, screening, and management guidance?